Poziotinib treatment in patients with HER2-positive advanced breast cancer who have received prior anti-HER2 regimens. Nasrazadani A, Marti JLG, Lathrop K, Restrepo A, et al. Breast Cancer Res Treat 2024 Jan 23. doi: 10.1007/s10549-023-07236.

Read + Share

Amedeo Smart

Independent Medical Education

Nasrazadani A, Marti JLG, Lathrop K, Restrepo A, et al. Poziotinib treatment in patients with HER2-positive advanced breast cancer who have received prior anti-HER2 regimens. Breast Cancer Res Treat 2024 Jan 23. doi: 10.1007/s10549-023-07236.
PMID: 38261228